VC  Temasek

http://www.temasek.com.sg/





     Office Locations:

23 King Street
London, SW1Y 6QY
United Kingdom
Phone: 44-20-7747-5040

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Growth


 

Industries:

  • Communications & Networking
  • Consumer Products & Services
  • Energy & Clean Tech
  • Financial Services
  • Life Sciences & Healthcare
  • Media & Digital Media
  • Real Estate & Construction
  • Transportation & Distribution

  •  

    Description:

    Incorporated in 1974, Temasek is an investment company based in Singapore. Supported by 11 offices globally, Temasek owns a S$242 billion portfolio as at 31 March 2016, mainly in Singapore and Asia. Temasek's investment themes center on: Transforming Economies; Growing Middle Income Populations; Deepening Comparative Advantages; and Emerging Champions. Its portfolio covers a broad spectrum of industries: financial services; telecommunications, media and technology; transportation and industrials; life sciences, consumer and real estate; as well as energy and resources. Temasek is governed by the provisions of the Singapore Company Act.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Benoit Valentin Senior Managing Director
    Gregory Curl President
    Ho Ching Executive Director & CEO
    Lee Theng Kiat Executive Director & CEO
    Luigi Feola Senior Managing Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      08/14/2018


      Orchard Therapeutics


      MA


      $150,000,000


      Series C


      08/09/2018


      Akili Interactive


      


      $13,000,000


      Series C


      07/29/2018


      Flywire


      MA


      $100,000,000


      Series D


      07/27/2018


      ClassPass


      NY


      $85,000,000


      Series D


      06/11/2018


      Claroty


      NY


      $60,000,000


      Series B


      05/23/2018


      Iora Health


      MA


      $100,000,000


      Series E


      05/09/2018


      Akili Interactive Labs


      MA


      $55,000,000


      Series C


      04/03/2018


      Impossible Foods


      CA


      $114,000,000


      


      03/05/2018


      C2FO


      KS


      $100,000,000


      


      03/01/2018


      Perfect Day


      CA


      $24,700,000


      Series A


      02/28/2018


      Viela Bio


      MD


      $250,000,000


      Series A


      02/17/2018


      Harry's


      NY


      $112,000,000


      Series D


      01/25/2018


      Stem


      CA


      $80,000,000


      Series D


      01/22/2018


      Bolt Threads


      CA


      $123,000,000


      Series D


      01/02/2018


      PEAR Therapeutics


      MA


      $50,000,000


      Series B


      11/30/2017


      Farmers Business Network


      CA


      $110,000,000


      Series D


      11/16/2017


      Poshmark


      CA


      $87,500,000


      Series D


      11/15/2017


      Arterys


      CA


      $30,000,000


      Series B


      10/17/2017


      Magic Leap


      FL


      $502,000,000


      Series D


      10/10/2017


      Bill.com


      CA


      $100,000,000


      


     

    Portfolio companies include:


      Airtel
        web link


      Akili Interactive


      Akili Interactive Labs
        web link


      Alibaba Group
        web link


      Arterys
        web link


      Bill.com
        web link


      Bolt Threads
        web link


      C2FO
        web link


      Calysta Energy
        web link


      CardioDx
        web link


      Celltrion
        web link


      Claroty
        web link


      ClassPass
        web link


      Dufry
        web link


      Farmers Business Network
        web link


      Flux
        web link


      Flywire
        web link


      Gilead Sciences


      Harry's
        web link


      Homology Medicines
        web link


      Impossible Foods
        web link


      Intapp
        web link


      InTouch Holdings
        web link


      Iora Health
        web link


      Krux
        web link


      Magic Leap
        web link


      Marin Software
        web link


      MarkIt
        web link


      Mediacorp
        web link


      Modern Meadow
        web link


      Olam
        web link


      Orchard Therapeutics
        web link


      PEAR Therapeutics
        web link


      Perfect Day
        web link


      Poshmark
        web link


      Singtel
        web link


      Sprinklr
        web link


      Stem
        web link


      Viela Bio
        web link


      Visterra
        web link


     

    Recent News:


      There is no recent news for Temasek.